Article

CDC confirms Fusarium keratitis cases

The U.S. Centers for Disease Control and Prevention (CDC) hasconfirmed 73 cases of Fusarium keratitis, dating back toJune 2005. Another 113 cases remain under investigation.

The U.S. Centers for Disease Control and Prevention (CDC) has confirmed 73 cases of Fusarium keratitis, dating back to June 2005. Another 113 cases remain under investigation.

Ophthalmologists from the Bascom Palmer Eye Institute at the University of Miami School of Medicine, Miami, and Wilmer Eye Institute at Johns Hopkins University School of Medicine, Baltimore, are working with the CDC and the FDA on the investigation.

As of April 27, the following states/territories had confirmed cases or cases under investigation: Arizona, Arkansas, California, Connecticut, Florida, Georgia, Illinois, Iowa, Kansas, Kentucky, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Nebraska, New Jersey, New York, North Carolina, North Dakota, Ohio, Oregon Pennsylvania, Puerto Rico, Rhode Island, Tennessee, Texas, and Vermont.

CDC officials say investigations are under way to pinpoint a source conclusively. There has not been a definitive link confirmed between the infections and Bausch & Lomb's Renu with MoistureLoc contact lens solution or the plant where it is manufactured, but consumers are urged to refrain from using the solution. The company has asked retailers to pull the product temporarily from shelves.

For in-depth coverage of this story, see the May 15 issue of Ophthalmology Times.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.